Immunocore Holdings plc Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -87.36M-179.64M-52.54M-55.29M-51.09M
Depreciation and Depletion 8.56M8.36M11.53M7.59M5.33M4.09M4.20M
Share-based Compensation 0.89M3.90M10.48M48.89M32.89M32.47M34.19M
Deferred Taxes 2.24M-0.88M-1.05M-0.62M-1.87M
Gains from Investment Securities 17.04M0.77M8.97M-1.84M
Non-cash Items -0.05M109.75M336.12M5.76M
Change in Working Capital -3.68M0.23M0.08M
Change in Receivables -2.03M2.33M-0.68M4.86M26.26M17.87M12.35M
Change in Account Payables 7.08M12.70M-4.85M1.47M4.91M2.62M7.27M
Change in Accured Expenses 10.68M41.76M39.09M71.50M
Change in Taxes 13.27M12.70M
Other Working Capital Changes -29.07M-25.50M15.01M11.60M
Cash from Operations -23.13M-148.60M-130.40M-143.11M-49.21M2.94M26.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.40M0.27M2.08M2.08M1.65M1.91M
Depreciation & Amortization (CF) 8.56M8.36M11.53M7.60M5.30M4.10M4.20M
Investing Activities
Capital Expenditures 4.66M5.21M3.95M1.39M2.20M5.42M5.17M
Sales of Property, Plant and Equipment 45.54M0.10M3.19M0.11M0.01M0.04M
Change in Acquisitions & Divestments 4.06M0.02M2.95M
Cash from Investing Activities 77.48M-3.34M1.47M-1.28M-2.20M-5.42M-355.13M
Financing Activities
Other financing activities 1.77M13.36M
Cash from Financing Activities 0.13M70.39M148.89M288.19M145.44M34.35M343.88M
Additional items
Exchange Rate Effect 0.02M-0.04M-0.11M0.62M-12.65M8.29M-1.71M
Change in Cash 55.41M-64.33M71.70M143.80M94.04M31.86M14.81M
Beginning Cash Balance -55.41M64.33M-71.70M-143.80M308.44M410.76M440.92M
Free Cash Flow -27.79M-153.81M-134.35M-144.49M-51.41M-2.48M20.89M
Net Cash Flow 54.48M-81.55M19.95M143.80M94.04M31.86M14.81M